ETH Zurich | S Lee/B Snijder
Researchers at ETH Zurich have used a drug screening platform they developed to show that an antidepressant, currently on the market, kills tumour cells in the dreaded glioblastoma – at least in the cell-culture dish. Above: Glioblastoma cells under the microscope.